BioLife Solutions, Inc. (BLFS)
37.22
+0.12
(+0.32%)
USD |
NASDAQ |
Aug 24, 16:00
37.22
0.00 (0.00%)
After-Hours: 20:00
BioLife Solutions Debt to Equity Ratio : 0.0375 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0375 |
| March 31, 2026 | 0.0399 |
| December 31, 2025 | 0.0481 |
| September 30, 2025 | 0.0585 |
| June 30, 2025 | 0.0686 |
| March 31, 2025 | 0.0764 |
| December 31, 2024 | 0.0861 |
| September 30, 2024 | 0.1207 |
| June 30, 2024 | 0.1119 |
| March 31, 2024 | 0.1229 |
| December 31, 2023 | 0.1002 |
| September 30, 2023 | 0.1331 |
| June 30, 2023 | 0.1266 |
| March 31, 2023 | 0.1207 |
| December 31, 2022 | 0.12 |
| September 30, 2022 | 0.1074 |
| June 30, 2022 | 0.0627 |
| March 31, 2022 | |
| December 31, 2021 | 0.0562 |
| September 30, 2021 | 0.0577 |
| June 30, 2021 | 0.0653 |
| March 31, 2021 | 0.0644 |
| December 31, 2020 | 0.0543 |
| September 30, 2020 | 0.004 |
| June 30, 2020 | 0.0091 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0171 |
| December 31, 2019 | 0.0312 |
| September 30, 2019 | 0.0201 |
| June 30, 2019 | 0.0323 |
| March 31, 2019 | 0.0374 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 1.404 |
| December 31, 2016 | 0.8983 |
| September 30, 2016 | 0.2841 |
| June 30, 2016 | 0.0963 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Repligen Corp. | 0.3271 |
| Agilent Technologies, Inc. | 0.4711 |
| Danaher Corp. | 0.5298 |
| Thermo Fisher Scientific, Inc. | 0.8077 |
| West Pharmaceutical Services, Inc. | 0.1058 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 447.49M |
| Total Liabilities (Quarterly) | 27.49M |
| Shareholders Equity (Quarterly) | 420.00M |
| Current Ratio | 9.694 |
| Net Debt Paydown Yield | 0.16% |